The new Democratic leadership addressed a number of their priorities during the first “100 hours” of this 110th Congress. The House voted to implement new ethics reforms, boost the
minimum wage, expand federal funding for stem cell research, implement additional homeland security initiatives, make changes to national energy policy, cut student loan interest rates and
authorized the government to negotiate prices for drugs covered under the Medicare program. We still await Senate action on these issues and to see what changes that chamber might make in
their versions of these bills.
minimum wage, expand federal funding for stem cell research, implement additional homeland security initiatives, make changes to national energy policy, cut student loan interest rates and
authorized the government to negotiate prices for drugs covered under the Medicare program. We still await Senate action on these issues and to see what changes that chamber might make in
their versions of these bills.
Author(s)
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.